In our study, the Complement titers (C3, C4 and CH50) were lower in the non-NPSLE group than in the NPSLE group, indicating that the non-NPSLE group had higher SLE disease activity (Table 1). The gene discussed is C3; the disease is systemic lupus erythematosus.